Eteplirsen approved in US for treatment of duchenne muscular dystrophy
Tuesday, September 20, 2016 - 22:31
in Health & Medicine
The U.S. Food and Drug Administration has decided to grant accelerated approval for eteplirsen, the first disease-modifying drug to treat the most common childhood form of muscular dystrophy.